IRVINE, Calif.-- (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that RD SET™ sensors with Masimo Measure-through Motion and Low Perfusion™ SET ® pulse oximetry have received FDA clearance ...

Normally, chasing rainbows is an inherently futile act. Masimo’s pursuit, however, is the rare one proven fruitful, with a new CE mark for its Rainbow SuperSensor. The single-use, adhesive SuperSensor ...

Philips and Masimo have renewed a longstanding strategic partnership to develop patient care solutions. This time, the companies stated that their collaboration would primarily focus on advancing ...

Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data ...

Masimo has earned a CE mark for a reusable finger sensor that noninvasively measures a range of physiological parameters at the same time. This reduces the need to use multiple sensors in patient ...

MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...

Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...

Masimo Corporation MASI recently announced the receipt of the FDA’s clearance for Stork for prescription use with healthy and sick infants aged 0-18 months of age. Stork, Masimo’s innovative baby ...

(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...